156 related articles for article (PubMed ID: 9783486)
1. The heart in the hypertensive elderly.
Grodzicki T; Messerli FH
J Hum Hypertens; 1998 Sep; 12(9):593-7. PubMed ID: 9783486
[TBL] [Abstract][Full Text] [Related]
2. Hypertension and Organ Damage in Women.
Muiesan ML; Paini A; Aggiusti C; Bertacchini F; Rosei CA; Salvetti M
High Blood Press Cardiovasc Prev; 2018 Sep; 25(3):245-252. PubMed ID: 29943358
[TBL] [Abstract][Full Text] [Related]
3. Early target organ damage and its reversibility: the heart.
Rosei EA; Muiesan ML
Clin Exp Hypertens; 2004; 26(7-8):673-87. PubMed ID: 15702622
[TBL] [Abstract][Full Text] [Related]
4. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
Ketelhut S; Franz IW; Ketelhut RG
High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
[TBL] [Abstract][Full Text] [Related]
5. The importance of left ventricular hypertrophy in human hypertension.
Kahan T
J Hypertens Suppl; 1998 Sep; 16(7):S23-9. PubMed ID: 9855028
[TBL] [Abstract][Full Text] [Related]
6. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and clinical aspects of hypertensive hypertrophy.
Vogt M; Motz WH; Schwartzkopf B; Strauer BE
Eur Heart J; 1993 Jul; 14 Suppl D():2-7. PubMed ID: 8103741
[TBL] [Abstract][Full Text] [Related]
10. Hypertensive heart disease.
Diamond JA; Phillips RA
Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
[TBL] [Abstract][Full Text] [Related]
11. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular hypertrophy. Prevalence in older patients and management.
Paciaroni E; Fraticelli A
Drugs Aging; 1995 Apr; 6(4):301-11. PubMed ID: 7613019
[TBL] [Abstract][Full Text] [Related]
13. Etiology, pathophysiology, and treatment of left ventricular hypertrophy: focus on severe hypertension.
Phillips RA
J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S55-62. PubMed ID: 7692152
[TBL] [Abstract][Full Text] [Related]
14. Effects of losartan on left ventricular mass: a three-year follow-up in elderly hypertensives with myocardial hypertrophy despite successful conventional antihypertensive treatment.
Moroni C; Tolone S; Lopreiato F; Scrofani AR; Bossini A; Affricano C; Cassone R; Gaudio C
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1323-1328. PubMed ID: 28387895
[TBL] [Abstract][Full Text] [Related]
15. Prevention and reduction of left ventricular hypertrophy in the elderly.
Lavie CJ; Milani RV; Messerli FH
Clin Geriatr Med; 1996 Feb; 12(1):57-68. PubMed ID: 8653663
[TBL] [Abstract][Full Text] [Related]
16. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
Okin PM; Devereux RB; Liu JE; Oikarinen L; Jern S; Kjeldsen SE; Julius S; Wachtell K; Nieminen MS; Dahlöf B
J Hum Hypertens; 2004 Jun; 18(6):403-9. PubMed ID: 15057252
[TBL] [Abstract][Full Text] [Related]
17. Development of Left Ventricular Hypertrophy in Treated Hypertensive Outpatients: The Campania Salute Network.
Izzo R; Losi MA; Stabile E; Lönnebakken MT; Canciello G; Esposito G; Barbato E; De Luca N; Trimarco B; de Simone G
Hypertension; 2017 Jan; 69(1):136-142. PubMed ID: 27895192
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension.
Clement DL; De Buyzere M; Duprez D
Am J Hypertens; 1993 Mar; 6(3 Pt 2):14S-19S. PubMed ID: 8466720
[TBL] [Abstract][Full Text] [Related]
19. Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey).
Erküner Ö; Dudink EAMP; Nieuwlaat R; Rienstra M; Van Gelder IC; Camm AJ; Capucci A; Breithardt G; LeHeuzey JY; Lip GYH; Crijns HJGM; Luermans JGLM
Am J Cardiol; 2018 Aug; 122(4):578-583. PubMed ID: 29958714
[TBL] [Abstract][Full Text] [Related]
20. Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension and their influences on prognosis.
Bayés-Genís A; Guindo J; Viñolas X; Tomás L; Elosua R; Duran I; Bayés de Luna A
Am J Cardiol; 1995 Nov; 76(13):54D-59D. PubMed ID: 7495219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
